Avoiding exploitation in multinational covid-19 vaccine trials

, , &
The BMJ 372:n541 (2021)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

COVID-19 vaccine trial ethics once we have efficacious vaccines.David Wendler, Jorge Ochoa, Joseph Millum, Christine Grady & Holly Taylor - 2020 - Science 370 (6522):1277-1279.
COVID-19 human challenge trials – what research ethics committees need to consider.Lisa Tambornino & Dirk Lanzerath - 2020 - Research Ethics 16 (3-4):1-11.
Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation.Matt Lamkin & Carl Elliott - 2018 - Journal of Law, Medicine and Ethics 46 (1):52-63.
Ethical allocation of future COVID-19 vaccines.Rohit Gupta & Stephanie R. Morain - 2021 - Journal of Medical Ethics 47 (3):137-141.
Ethical considerations for epidemic vaccine trials.Joshua Teperowski Monrad - 2020 - Journal of Medical Ethics 46 (7):465-469.
Ethical guidelines for deliberately infecting volunteers with COVID-19.Adair D. Richards - 2020 - Journal of Medical Ethics 46 (8):502-504.
Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.Rika Moorhouse, Catherine Slack, Michael Quayle, Zaynab Essack & Graham Lindegger - 2014 - BMC Medical Ethics 15 (1):51.
Multivalue ethical framework for fair global allocation of a COVID-19 vaccine.Yangzi Liu, Sanjana Salwi & Brian C. Drolet - 2020 - Journal of Medical Ethics 46 (8):499-501.
Pandemic Ethics: 8 Big Questions of COVID-19.Ben Bramble - 2020 - Sydney: Bartleby Books.
To What Extent Are Calls for Greater Minority Representation in COVID Vaccine Research Ethically Justified?Angela Ballantyne & Agomoni Ganguli-Mitra - 2021 - American Journal of Bioethics 21 (2):99-101.
Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.Robert Steel, Lara Buchak & Nir Eyal - 2020 - Journal of Medical Ethics 46 (12):808-812.
Equitable Access to Research Benefits: Considerations for COVID-19 Vaccine Development and Clinical Trial Crossover.Danish Zaidi, Jennifer Miller, Tanvee Varma, Dowin Boatright & Phoebe Friesen - 2021 - American Journal of Bioethics 21 (3):86-88.
Hiv vaccine trials: Reconsidering the therapeutic misconception and the question of what constitutes trial related injuries.Udo Schüklenk & Richard Ashcroft - 2007 - Developing World Bioethics 7 (3):ii–iv.
Exploitations and their complications: The necessity of identifying the multiple forms of exploitation in pharmaceutical trials.Jeremy Snyder - 2012 - Bioethics 26 (5):251-258.
A new vaccine for tuberculosis: The challenges of development and deployment. [REVIEW]Helen A. Fletcher, Tony Hawkridge & Helen McShane - 2009 - Journal of Bioethical Inquiry 6 (2):219-228.

Analytics

Added to PP
2021-03-31

Downloads
268 (#71,854)

6 months
73 (#57,598)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Joseph Millum
University of St. Andrews

Citations of this work

Add more citations

References found in this work

No references found.

Add more references